Nuo Therapeutics, Inc. (AURX) Capital expenditures 2019–2025
Nuo Therapeutics, Inc. (AURX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$274,756FY2025 · since FY2019: $0 → $274,756
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $274,756 | +77.3% |
| FY2024 | $154,962 | +2039.2% |
| FY2023 | $7,244 | -87.9% |
| FY2022 | $59,992 | — |
| FY2021 | $0 | — |
| FY2020 | $0 | — |
| FY2019 | $0 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice